Dr. Sangmee Bae, MD

Dr. Bae practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Bae's NPI, 1003172529, was assigned on April 10, 2012. Dr. Bae graduated from Other in 2010. Dr. Bae holds California license A132195.

Dr. Bae's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Bae's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Bae to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bae practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Bae's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Bae is board certified in internal medicine by the American Board of Internal Medicine. Dr. Bae is licensed in California.

Dmand AI lists arteritis, arthritis, fluid in a joint, lupus, muscle disease and rheumatoid arthritis among the conditions Dr. Bae treats.

CMS data shows 141 Medicare services from Dr. Bae across 4 procedure codes in 2024, for 60 Medicare patients. Medicare paid $10,956 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Bae in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have arthritis, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bae's median patient age at 53, with 65% women.

In 2024, Dr. Bae wrote 411 Medicare Part D claims for 32 patients. 59% of them were for generic drugs. CMS names the drug for 324 of them, across 12 drugs with 11 or more claims each, at $1,276,655 in total drug cost. In 2023, CMS named 243 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bae for performance year 2024, reported as part of a group. Dr. Bae accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bae as offering telehealth.

Dmand AI links 6 papers to Dr. Bae, published from 2010 to 2025. 2012 was the busiest year, with 2. Dr. Bae's most frequent co-authors are Manjit Singh, MD, Rohit Aggarwal, MD and Dana P. Ascherman, MD.

Dmand AI links Dr. Bae to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 6 general payments to Dr. Bae from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 58% of the total. Gilead Sciences, Inc. paid the most, $407.

Dr. Bae graduated from Other in 2010.

Dr. Bae is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.